Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure
- PMID: 11717593
- DOI: 10.1067/mhj.2001.119611
Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure
Comment on
-
Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trial.Am Heart J. 2001 Dec;142(6):982-8. doi: 10.1067/mhj.2001.118742. Am Heart J. 2001. PMID: 11717601 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical